ピリミジン化合物、組成物、及びその医薬用途

Title:

ピリミジン化合物、組成物、及びその医薬用途

Document Type and Number:

Japanese Patent JP2023549074

Kind Code:

A

Abstract:

本開示は、ピリミジン化合物の類、それらの立体異性体、互変異性体、医薬として許容可能なその塩、立体異性体、溶媒和物、及び、水和物に関する。また、本開示は、これらのピリミジン化合物、これらの化合物を含有する医薬組成物の製造方法、及び、それらの医薬用途にも関する。【選択図】なし

More Like This:

WO/2014/098045	PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, METAL COMPLEX DYE, DYE SOLUTION, DYE-ABSORBED ELECTRODE, AND METHOD FOR MANUFACTURING DYE-SENSITIZED SOLAR CELL
WO2003009845	SUBSTITUTED UREA NEUROPEPTIDE Y Y5 RECEPTOR ANTAGONISTS
JP4528125	Sulfonylamino-acetic acid derivative

Inventors:

Haruru, Guru Ringappa
Madhyastha, Nabina
Stephen, Michael Rajesh
ross, blues
Pandy, Anjali
Saxton, Tracy

Application Number:

JP2023526219A

Publication Date:

November 22, 2023

Filing Date:

October 30, 2021

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Blueprint Medicines Corporation

International Classes:

C07D401/14; A61K31/506; A61K31/5377; A61K31/55; A61K31/553; A61P9/10; A61P17/00; A61P17/04; A61P17/06; A61P29/00; A61P35/00; A61P43/00; C07D403/12; C07D403/14; C07D405/14; C07D413/14

Attorney, Agent or Firm:

Osamu Yamamoto
Toru Miyamae
Junichi Matsuo
Tsurugi Toshitaka

Previous Patent: Methods for protecting fuel cell system components

Next Patent: Use of anti-CD19 antibodies to treat autoimmune diseases